Title: HOUSE BILL 1004
Official Title: HOUSE BILL 1004
Number of Sections: 1
Source: versions - Third - Public Health - Alzheimer's Disease and Related Dementias - Information on Prevalence and Treatment
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
J1 5lr2242
CF SB 748
By: Delegate Martinez Delegates Martinez, Alston, Bagnall, Bhandari, Cullison,
Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, Kipke, Lopez,
Pena–Melnyk, Reilly, Rosenberg, Ross, Taveras, White Holland, Woods, and
Woorman
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 6, 2025
CHAPTER ______
1 AN ACT concerning
2 Public Health – Alzheimer’s Disease and Related Dementias – Information on
3 Prevalence and Treatment
4 FOR the purpose of requiring the Maryland Department of Health, in partnership with
5 certain entities, to incorporate information regarding treatments approved by the
6 Food and Drug Administration for Alzheimer’s disease and related dementias and to
7 increase understanding and awareness of treatment of Alzheimer’s disease and
8 related dementias into relevant public health outreach programs administered by
9 the Department; requiring the Department to establish and maintain a website that
10 includes certain information on the prevalence and hospitalization rate of
11 Alzheimer’s disease and related dementias; and generally related to Alzheimer’s
12 disease and related dementias.
13 BY repealing and reenacting, with amendments,
14 Article – Health – General
15 Section 18–110
16 Annotated Code of Maryland
17 (2023 Replacement Volume and 2024 Supplement)
18 BY adding to
19 Article – Health – General
20 Section 18–111
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1004*
2 HOUSE BILL 1004
1 Annotated Code of Maryland
2 (2023 Replacement Volume and 2024 Supplement)
3 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
4 That the Laws of Maryland read as follows:
5 Article – Health – General
6 18–110.
7 The Department, in partnership with the Department of Aging, the Virginia I. Jones
8 Alzheimer’s Disease and Related Disorders DEMENTIAS Council, and the Greater
9 Maryland Chapter of the Alzheimer’s Association, shall incorporate information into
10 relevant public health outreach programs administered by the Department to:
11 (1) Educate health care providers regarding:
12 (i) The importance of early detection and timely diagnosis of
13 cognitive impairment;
14 (ii) Validated assessment tools for the detection and diagnosis of
15 cognitive impairment;
16 (iii) The value of a Medicare annual wellness visit or other annual
17 physical for an individual at least 65 years old for cognitive health; [and]
18 (iv) The Medicare care planning billing code for individuals with
19 cognitive impairment; and
20 (V) TREATMENTS APPROVED BY THE FOOD AND DRUG
21 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS,
22 INCLUDING RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES; AND
23 (2) Increase PUBLIC understanding and awareness of:
24 (i) The early warning signs of Alzheimer’s disease and [other types
25 of dementia] RELATED DEMENTIAS;
26 (ii) The value of early detection [and], diagnosis, AND TREATMENT
27 of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and
28 (iii) How to reduce the risk of cognitive decline, particularly among
29 individuals in Black and Latino communities who are at greater risk of developing
30 Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; AND
HOUSE BILL 1004 3
1 (IV) TREATMENTS APPROVED BY THE U.S. FOOD AND DRUG
2 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS AND
3 RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES, INCLUDING
4 INFORMATION RELATED TO TREATMENT OUTCOMES BASED ON BIOLOGICAL SEX.
5 18–111.
6 (A) THE DEPARTMENT, IN COLLABORATION WITH THE STATE–DESIGNATED
7 HEALTH INFORMATION EXCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY
8 ACCESSIBLE WEBSITE THAT INCLUDES IN A DOWNLOADABLE FORMAT THE
9 FOLLOWING INFORMATION:
10 (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATED
11 DEMENTIAS IN THE STATE;
12 (2) THE HOSPITALIZATION RATE RELATED TO ALZHEIMER’S DISEASE
13 AND RELATED DEMENTIAS; AND
14 (3) TO THE EXTENT POSSIBLE, THE PREVALENCE AND
15 HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
16 DISAGGREGATED BASED ON:
17 (I) AGE, INCLUDING AGE OF DIAGNOSIS;
18 (II) SEX;
19 (III) RACE;
20 (IV) ETHNICITY; AND
21 (V) NUMBER OF CASES BY COUNTY;
22 (VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY–21);
23 AND
24 (VII) TYPE OF DEMENTIA.
25 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION
26 SHALL:
27 (1) INCLUDE THE DATA AVAILABLE FOR THE IMMEDIATELY
28 PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND
4 HOUSE BILL 1004
1 (2) BE UPDATED ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING
2 IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA.
3 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
4 October 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.
[DELETED: :CA      5   C H H S K K K L A P P F c F i u a a o t o A d a r t i c i o t p a h r o A d a r d a g r t A d B  A S  A  ( B  A S]
[DELETED:  H   A  (  S T A 1  T A D a R D  C a t G M C o t A A s i i i r   ( E    ( T i o e d a t d o c    ( V a t f t d a d o c    ( T p ad    ( T M c p b c f i w c   ) TFR A B T O A RA’ F LRS D A R DSS     ( I      ( T o oa;    ( T ad s], o oa;    ( H i i B a L c w a a g r o d A oa]S ]
[DELETED: H 3    )TU.FVR A B T  O A RA F LRS D A R D A I O T U A OS I . ) TD,SH ET  TEDE  W T I I A D F T   TA P O LRS D A R T;   TA LRSS    T T E PE T P A R O LRS D A R D   ) A,;GE    ) S;IE   ) R;IA    ) EVTY    ) N;UY    )C–DS(T–IOO O O Y RY      )TIY ) T(H W R U S A O T S    T D A F T I Y E   –S3,2;]
[DELETED:  H    BJ1 A  R   ,.  S A B I F E T t A s t e O          G               ]


================================================================================

Raw Text:
HOUSE BILL 1004
J1 5lr2242
CF SB 748
By: Delegate Martinez Delegates Martinez, Alston, Bagnall, Bhandari, Cullison,
Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, Kipke, Lopez,
Pena–Melnyk, Reilly, Rosenberg, Ross, Taveras, White Holland, Woods, and
Woorman
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 6, 2025
CHAPTER ______
1 AN ACT concerning
2 Public Health – Alzheimer’s Disease and Related Dementias – Information on
3 Prevalence and Treatment
4 FOR the purpose of requiring the Maryland Department of Health, in partnership with
5 certain entities, to incorporate information regarding treatments approved by the
6 Food and Drug Administration for Alzheimer’s disease and related dementias and to
7 increase understanding and awareness of treatment of Alzheimer’s disease and
8 related dementias into relevant public health outreach programs administered by
9 the Department; requiring the Department to establish and maintain a website that
10 includes certain information on the prevalence and hospitalization rate of
11 Alzheimer’s disease and related dementias; and generally related to Alzheimer’s
12 disease and related dementias.
13 BY repealing and reenacting, with amendments,
14 Article – Health – General
15 Section 18–110
16 Annotated Code of Maryland
17 (2023 Replacement Volume and 2024 Supplement)
18 BY adding to
19 Article – Health – General
20 Section 18–111
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb1004*

2 HOUSE BILL 1004
1 Annotated Code of Maryland
2 (2023 Replacement Volume and 2024 Supplement)
3 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
4 That the Laws of Maryland read as follows:
5 Article – Health – General
6 18–110.
7 The Department, in partnership with the Department of Aging, the Virginia I. Jones
8 Alzheimer’s Disease and Related Disorders DEMENTIAS Council, and the Greater
9 Maryland Chapter of the Alzheimer’s Association, shall incorporate information into
10 relevant public health outreach programs administered by the Department to:
11 (1) Educate health care providers regarding:
12 (i) The importance of early detection and timely diagnosis of
13 cognitive impairment;
14 (ii) Validated assessment tools for the detection and diagnosis of
15 cognitive impairment;
16 (iii) The value of a Medicare annual wellness visit or other annual
17 physical for an individual at least 65 years old for cognitive health; [and]
18 (iv) The Medicare care planning billing code for individuals with
19 cognitive impairment; and
20 (V) TREATMENTS APPROVED BY THE FOOD AND DRUG
21 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS,
22 INCLUDING RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES; AND
23 (2) Increase PUBLIC understanding and awareness of:
24 (i) The early warning signs of Alzheimer’s disease and [other types
25 of dementia] RELATED DEMENTIAS;
26 (ii) The value of early detection [and], diagnosis, AND TREATMENT
27 of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and
28 (iii) How to reduce the risk of cognitive decline, particularly among
29 individuals in Black and Latino communities who are at greater risk of developing
30 Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; AND

HOUSE BILL 1004 3
1 (IV) TREATMENTS APPROVED BY THE U.S. FOOD AND DRUG
2 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS AND
3 RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES, INCLUDING
4 INFORMATION RELATED TO TREATMENT OUTCOMES BASED ON BIOLOGICAL SEX.
5 18–111.
6 (A) THE DEPARTMENT, IN COLLABORATION WITH THE STATE–DESIGNATED
7 HEALTH INFORMATION EXCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY
8 ACCESSIBLE WEBSITE THAT INCLUDES IN A DOWNLOADABLE FORMAT THE
9 FOLLOWING INFORMATION:
10 (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATED
11 DEMENTIAS IN THE STATE;
12 (2) THE HOSPITALIZATION RATE RELATED TO ALZHEIMER’S DISEASE
13 AND RELATED DEMENTIAS; AND
14 (3) TO THE EXTENT POSSIBLE, THE PREVALENCE AND
15 HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
16 DISAGGREGATED BASED ON:
17 (I) AGE, INCLUDING AGE OF DIAGNOSIS;
18 (II) SEX;
19 (III) RACE;
20 (IV) ETHNICITY; AND
21 (V) NUMBER OF CASES BY COUNTY;
22 (VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY–21);
23 AND
24 (VII) TYPE OF DEMENTIA.
25 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION
26 SHALL:
27 (1) INCLUDE THE DATA AVAILABLE FOR THE IMMEDIATELY
28 PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND

4 HOUSE BILL 1004
1 (2) BE UPDATED ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING
2 IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA.
3 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
4 October 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      5   C H H S K K K L A P P F c F i u a a o t o A d a r t i c i o t p a h r o A d a r d a g r t A d B  A S  A  ( B  A S]
[DELETED:  H   A  (  S T A 1  T A D a R D  C a t G M C o t A A s i i i r   ( E    ( T i o e d a t d o c    ( V a t f t d a d o c    ( T p ad    ( T M c p b c f i w c   ) TFR A B T O A RA’ F LRS D A R DSS     ( I      ( T o oa;    ( T ad s], o oa;    ( H i i B a L c w a a g r o d A oa]S ]
[DELETED: H 3    )TU.FVR A B T  O A RA F LRS D A R D A I O T U A OS I . ) TD,SH ET  TEDE  W T I I A D F T   TA P O LRS D A R T;   TA LRSS    T T E PE T P A R O LRS D A R D   ) A,;GE    ) S;IE   ) R;IA    ) EVTY    ) N;UY    )C–DS(T–IOO O O Y RY      )TIY ) T(H W R U S A O T S    T D A F T I Y E   –S3,2;]
[DELETED:  H    BJ1 A  R   ,.  S A B I F E T t A s t e O          G               ]